In-Person + Virtual

25th Annual International Congress on the Future of Breast Cancer® East

July 10-11, 2026InterContinental New York Barclay111 East 48th Street, New York, NY 10017

Countdown to Event

14

Days

03

Hours

22

Mins

25

Secs

Overview

The 25th Annual International Congress on the Future of Breast Cancer® East will provide clinicians with cutting-edge updates on recent advances in the treatment of breast cancer, from preclinical breakthroughs to changes in clinical treatment paradigms. Novel agents and improved regimens, coupled with more in-depth molecular and phenotypic subtyping, are driving the future of breast cancer therapy. This dynamic program will focus on the practical implications of emerging data for patient care in the clinic. Recent data and their clinical impact are highlighted throughout the program, with expert perspectives on how to apply the evidence to individualize therapy for patients with breast cancer. Current areas of controversy or uncertainty will also be debated, with discussion of ongoing clinical trials and investigational approaches designed to address these questions.

This conference provides a unique opportunity for medical, surgical, and radiation oncologists and other health care professionals to learn from and interact with international leaders in the field of breast cancer to increase knowledge, apply new data to practice, and, ultimately, improve patient outcomes.

Learning Objectives

  • Integrate genomic and molecular biomarker findings into individualized treatment strategies for patients with early-stage and metastatic breast cancer
  • Formulate multidisciplinary locoregional management strategies incorporating contemporary imaging, surgical, and radiation approaches
  • Evaluate emerging data from key clinical trials and their implications for the management of early-stage and advanced/metastatic breast cancer
  • Apply current evidence and guideline recommendations to develop stage-specific, personalized treatment plans for patients with breast cancer
  • Implement evidence-based strategies to prevent and manage treatment-related adverse events in breast cancer care

Program Chair

Joyce O'Shaughnessy, MD

To view full profile, click on the Program Chair tab above.

Event Details

  • Start Date
    July 10, 2026
  • End Date
    July 11, 2026
  • Location
    New York, NY
  • Venue
    InterContinental New York Barclay
    111 East 48th Street
    New York, NY 10017, USA
    Phone: 212-755-5900
    View Accommodations
  • Target Audience
    This educational activity is intended for medical, surgical, and radiation oncologists involved in the treatment of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of breast cancer may also participate.

This activity is supported by educational grants from Exact Sciences Corporation; Novartis Pharmaceuticals Corporation; and Puma Biotechnology, Inc.

PER is proud to partner with Empire State Hematology & Oncology Society.

Follow Us on Social Media!

Ready to attend?

Secure your spot at 25th Annual International Congress on the Future of Breast Cancer® East.